HC Wainwright & Co. : Maintain the Fate Therapeutics (FATE.US) rating, adjust from neutral to neutral, and adjust the target price from $7.00 to $5.00.
HC Wainwright & Co.：维持Fate Therapeutics(FATE.US)评级，由中性调整至中性评级, 目标价由7.00美元调整至5.00美元。
HC Wainwright & Co. : Maintain the Fate Therapeutics (FATE.US) rating, adjust from neutral to neutral, and adjust the target price from $7.00 to $5.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.